About
Cell & Gene Therapy Consulting
Areas of Focus
Categories
BiotechCg Regulatory
Team (58)
Clinical Trials (3)
View allTotal Trials
3
As Lead Sponsor
0
As Collaborator
3
Total Enrollment
755
By Phase
PHASE2: 2PHASE3: 1
By Status
RECRUITING: 1ACTIVE_NOT_RECRUITING: 1UNKNOWN: 1
Clinical Trials Pipeline3 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
Today
Hover over trial bars to see details
Recent Trials
NCT05468073Collaborator
Therapeutic Evaluation of Low-dose IL-2-based Immunomodulatory Approach in Patients With Early AD
PHASE2Recruiting
45 participants
Started: Oct 11, 2022 · Completed: Sep 1, 2026
NCT03576417Collaborator
A Trial Evaluating the Addition of Nivolumab to Cisplatin-RT for Treatment of Cancers of the Head and Neck
PHASE3Active, not recruiting
680 participants
Started: Oct 10, 2018 · Completed: Sep 30, 2027
NCT02957760Collaborator
Prevention of Retinal Non-perfusion in Central Retinal Vein Occlusion by Hydroxycarbamide Treatment.
PHASE2Unknown
30 participants
Started: Dec 31, 2015 · Completed: Dec 31, 2017
Locations (1)
Headquarters
Walnut Creek, CA, United States
Map
Loading map...